進行中(不再收案) NCT07395570

CADe系統偵測胃部腫瘤之療效

胃癌不適用I 期II 期

胃癌仍是全球第五常見的癌症,其癌症相關死亡率亦排名第五,每年造成超過650,000人死亡。胃癌的存活與確診時的期數直接相關,早期癌症的存活明顯較佳。第I期胃癌患者的五年存活率一般超過90%。

適應症:Gastric Neoplasia

收案條件

納入條件

  • Age \>=18
  • Deemed at high risk of gastric cancer, defined as below:
  • Family history of stomach cancer (1st degree relative) for screening, or
  • Known gastric atrophy/ intestinal metaplasia requiring surveillance, or
  • Suspicious lesion for repeat diagnostic OGD, or
  • History of gastric dysplasia / early gastric cancer with endoscopic resection for surveillance
  • Newly diagnosed early gastric cancer, workup for synchronous cancers

排除條件

  • History of gastrectomy (For any reason, including benign and malignant disease)
  • Patient who refused to participate
  • Patients deemed not fit for consent, including minor patients
  • Pregnancy
  • Other cases deemed by the examining physician as unsuitable for safe treatment

收案條件維持 ClinicalTrials.gov 原始英文登錄資料,實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源:ClinicalTrials.gov,每兩週自動更新,最後同步:2026年10月8日。